UK markets closed

Omeros Corporation (OMER)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
5.87-0.14 (-2.33%)
At close: 04:00PM EDT
6.27 +0.40 (+6.81%)
After hours: 05:40PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close6.01
Open5.96
Bid5.80 x 1800
Ask6.29 x 1300
Day's range5.80 - 6.15
52-week range1.86 - 16.57
Volume419,933
Avg. volume1,459,614
Market cap406.212M
Beta (5Y monthly)1.13
PE ratio (TTM)1.87
EPS (TTM)3.14
Earnings date07 Nov 2022 - 11 Nov 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est18.40
  • Business Wire

    Omeros Corporation Receives Interim Response from FDA on Formal Dispute Resolution Request for Narsoplimab

    SEATTLE, August 17, 2022--Omeros Corporation (Nasdaq: OMER) today announced that the United States Food and Drug Administration (FDA) provided an interim response to the company’s formal dispute resolution request submitted to the Agency in June, appealing the earlier decision by the FDA review division to issue a complete response letter for the biologics license application (BLA) for narsoplimab in the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-

  • Business Wire

    Omeros Corporation Reports Second Quarter 2022 Financial Results

    SEATTLE, August 09, 2022--Omeros Corporation (Nasdaq: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation and immunologic diseases, including complement-mediated diseases and cancers, today announced recent highlights and developments as well as financial results for the second quarter ended June 30, 2022, which include:

  • Simply Wall St.

    How Much Of Omeros Corporation (NASDAQ:OMER) Do Institutions Own?

    A look at the shareholders of Omeros Corporation ( NASDAQ:OMER ) can tell us which group is most powerful. Large...